L & S Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,616
| Closed | -$838K | – | 308 |
|
|
2023
Q1 | $838K | Sell |
8,616
-4,095
| -32% | -$398K | 0.12% | 170 |
|
|
2022
Q4 | $1.32M | Buy |
12,711
+3,331
| +36% | +$345K | 0.24% | 100 |
|
|
2022
Q3 | $795K | Buy |
+9,380
| New | +$795K | 0.14% | 141 |
|
|
2020
Q3 | – | Sell |
-8,859
| Closed | -$1.09M | – | 302 |
|
|
2020
Q2 | $1.09M | Buy |
8,859
+419
| +5% | +$51.7K | 0.16% | 160 |
|
|
2020
Q1 | $713K | Sell |
8,440
-125
| -1% | -$10.6K | 0.13% | 144 |
|
|
2019
Q4 | $724K | Buy |
8,565
+1,450
| +20% | +$123K | 0.09% | 183 |
|
|
2019
Q3 | $480K | Sell |
7,115
-3,099
| -30% | -$209K | 0.07% | 238 |
|
|
2019
Q2 | $875K | Buy |
10,214
+729
| +8% | +$62.5K | 0.12% | 191 |
|
|
2019
Q1 | $843K | Buy |
9,485
+1,690
| +22% | +$150K | 0.11% | 185 |
|
|
2018
Q4 | $664K | Sell |
7,795
-785
| -9% | -$66.9K | 0.12% | 161 |
|
|
2018
Q3 | $832K | Buy |
8,580
+1,625
| +23% | +$158K | 0.11% | 168 |
|
|
2018
Q2 | $655K | Buy |
+6,955
| New | +$655K | 0.11% | 178 |
|